A 3-year Follow-up Study of β-cell Function in Patients with Early-onset Type 2 Diabetes

Overview

Journal Exp Ther Med

Specialty Pathology

Date 2016 Jul 23

PMID 27446326

Citations 7

Authors

Shaoling Zhou

Xiaomei Meng

Shuyan Wang

Ruizhen Ren

Weikai Hou

Kuixiang Huang

Hongli Shi

Affiliations

Soon will be listed here.

Abstract

Insulin resistance and reduced β-cell glucose sensitivity are present in patients with type 2 diabetes. In the present study, we investigated the changes in β-cell function in patients with type 2 diabetes during a 3-year follow-up study. A total of 48 patients with early-onset type 2 diabetes (EOD) and 55 patients with late-onset type 2 diabetes (LOD) were enrolled. Weight, height, waist circumference, hip circumference, blood pressure and plasma levels of lipids, glucose, fasting serum C-peptide (CPR0) and serum C-peptide 6 min after glucagon stimulation (CPR6) were measured. In addition, islet β-cell secretory activity was detected. Subjects with EOD had lower Systolic blood pressure (SBP), diastolic blood pressure (DBP), body mass index (BMI), fasting CPR0, CPR6 and greater glycated hemoglobin A1c (HbA1c), triglyceride (TG) compared with subjects with LOD. CPR0, CPR6 and TG were decreased in both EOD and LOD groups 3 years later. The ratio of β-cell function failure was 29.17 and 10.91% in the EOD and LOD groups, respectively, and there was significant difference between the two groups. A positive correlation was identified between the CPR0 and waist-hip ratio, HbA1c in the EOD group. A similar positive correlation was observed between CPR0 and BMI in the LOD group. Collectively, islet β-cell function has declined in patients with EOD, and this change may be more evident when compared with those with LOD.

Citing Articles

Association of oxidative balance score with the risk of all-cause and CVD mortality in younger US adults with diabetes.

Liu C, Xiang G, Liang D, Zhao X, Xiao K, Xie L Sci Rep. 2025; 15(1):3609.

PMID: 39875577 PMC: 11775326. DOI: 10.1038/s41598-025-88132-y.

Insulin Inertia Among People With Type 2 Diabetes Mellitus in Qatar: The INERT-Q Study.

Bashir M, Thani N, Khalid A, Khalil O, Alamer Z, Hamad M Endocrinol Diabetes Metab. 2024; 7(4):e00495.

PMID: 38844642 PMC: 11156521. DOI: 10.1002/edm2.495.

GLP1R rs3765467 Polymorphism Is Associated with the Risk of Early Onset Type 2 Diabetes.

Fang Y, Zhang J, Ji L, Zhu C, Xiao Y, Gao Q Int J Endocrinol. 2023; 2023:8729242.

PMID: 38131033 PMC: 10735718. DOI: 10.1155/2023/8729242.

Association of Bedtime with Early-Onset Diabetes and Islet Beta Cell Function in Patients with Newly Diagnosed Type 2 Diabetes Mellitus.

Ma M, Jiang T, Zhang D, Yao X, Wen Z, Xiu L Nat Sci Sleep. 2023; 15:653-662.

PMID: 37609388 PMC: 10440600. DOI: 10.2147/NSS.S413992.

Association of lipid, inflammatory, and metabolic biomarkers with age at onset for incident cardiovascular disease.

Tian X, Chen S, Zuo Y, Zhang Y, Zhang X, Xu Q BMC Med. 2022; 20(1):383.

PMID: 36352412 PMC: 9647925. DOI: 10.1186/s12916-022-02592-x.

References

Chan J, Malik V, Jia W, Kadowaki T, Yajnik C, Yoon K . Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009; 301(20):2129-40. DOI: 10.1001/jama.2009.726. View

Poitout V, Robertson R . Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr Rev. 2007; 29(3):351-66. PMC: 2528858. DOI: 10.1210/er.2007-0023. View

Zhou Y, Grill V . Long term exposure to fatty acids and ketones inhibits B-cell functions in human pancreatic islets of Langerhans. J Clin Endocrinol Metab. 1995; 80(5):1584-90. DOI: 10.1210/jcem.80.5.7745004. View

. U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group. Diabetes. 1995; 44(11):1249-58. View

Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Mari A, DeFronzo R . beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab. 2004; 90(1):493-500. DOI: 10.1210/jc.2004-1133. View

Tura A, Mari A, Winzer C, Kautzky-Willer A, Pacini G . Impaired beta-cell function in lean normotolerant former gestational diabetic women. Eur J Clin Invest. 2006; 36(1):22-8. DOI: 10.1111/j.1365-2362.2006.01587.x. View

McCoy R, Van Houten H, Ross J, Montori V, Shah N . HbA1c overtesting and overtreatment among US adults with controlled type 2 diabetes, 2001-13: observational population based study. BMJ. 2015; 351:h6138. PMC: 4673101. DOI: 10.1136/bmj.h6138. View

Zhou Y, Grill V . Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin Invest. 1994; 93(2):870-6. PMC: 293952. DOI: 10.1172/JCI117042. View

van de Bunt M, Manning Fox J, Dai X, Barrett A, Grey C, Li L . Transcript Expression Data from Human Islets Links Regulatory Signals from Genome-Wide Association Studies for Type 2 Diabetes and Glycemic Traits to Their Downstream Effectors. PLoS Genet. 2015; 11(12):e1005694. PMC: 4666611. DOI: 10.1371/journal.pgen.1005694. View

10.

Leahy J, Bonner-Weir S, Weir G . Beta-cell dysfunction induced by chronic hyperglycemia. Current ideas on mechanism of impaired glucose-induced insulin secretion. Diabetes Care. 1992; 15(3):442-55. DOI: 10.2337/diacare.15.3.442. View

11.

Patel A, Barzi F, Jamrozik K, Lam T, Ueshima H, Whitlock G . Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region. Circulation. 2004; 110(17):2678-86. DOI: 10.1161/01.CIR.0000145615.33955.83. View

12.

Kaneto H, Xu G, Song K, Suzuma K, Bonner-Weir S, Sharma A . Activation of the hexosamine pathway leads to deterioration of pancreatic beta-cell function through the induction of oxidative stress. J Biol Chem. 2001; 276(33):31099-104. DOI: 10.1074/jbc.M104115200. View

13.

Shen J, Chen Z, Chen C, Zhu X, Han Y . Impact of incretin on early-phase insulin secretion and glucose excursion. Endocrine. 2013; 44(2):403-10. DOI: 10.1007/s12020-012-9867-9. View

14.

Bellin M, Beilman G, Dunn T, Pruett T, Chinnakotla S, Wilhelm J . Islet autotransplantation to preserve beta cell mass in selected patients with chronic pancreatitis and diabetes mellitus undergoing total pancreatectomy. Pancreas. 2012; 42(2):317-21. PMC: 3573248. DOI: 10.1097/MPA.0b013e3182681182. View

15.

Ovalle F, Bell D . Effect of rosiglitazone versus insulin on the pancreatic beta-cell function of subjects with type 2 diabetes. Diabetes Care. 2004; 27(11):2585-9. DOI: 10.2337/diacare.27.11.2585. View

16.

van Haeften T, Pimenta W, Mitrakou A, Korytkowski M, Jenssen T, Yki-Jarvinen H . Relative conributions of beta-cell function and tissue insulin sensitivity to fasting and postglucose-load glycemia. Metabolism. 2000; 49(10):1318-25. DOI: 10.1053/meta.2000.9526. View

17.

Shaw J, Sicree R, Zimmet P . Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2009; 87(1):4-14. DOI: 10.1016/j.diabres.2009.10.007. View

18.

Taskinen M . Type 2 diabetes as a lipid disorder. Curr Mol Med. 2005; 5(3):297-308. DOI: 10.2174/1566524053766086. View

19.

Gao W, Wang Q, Yu S . Efficacy, safety and impact on β-cell function of dipeptidyl peptidase-4 inhibitors plus metformin combination therapy in patients with type 2 diabetes and the difference between Asians and Caucasians: a meta-analysis. J Endocrinol Invest. 2016; 39(9):1061-74. DOI: 10.1007/s40618-016-0465-1. View

20.

Scheen A, Castillo M, Lefebvre P . Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: methodological aspects and clinical applications. Diabetes Metab. 1996; 22(6):397-406. View